Guerrilla RF director granted 14K stock options
Guerrilla RF, Inc. (GUER) director and 10% owner Thomas B. Ellis reported an award of 14,164 stock options with a $6.00 exercise price, expiring August 14, 2036.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Guerrilla RF, Inc. (GUER) director and 10% owner Thomas B. Ellis reported an award of 14,164 stock options with a $6.00 exercise price, expiring August 14, 2036. The option is immediately exercisable but subject to the issuer’s repurchase right until it vests on the earlier of the first anniversary of grant or the next annual stockholders’ meeting, currently expected June 9, 2027. Ellis also reports indirect interests in Series A Convertible Preferred Stock convertible into 7,213,115 common shares and warrants for 2,885,246 common shares, held through NR-PRL entities, for which he disclaims beneficial ownership beyond his pecuniary interest, plus direct ownership of 32,292 common shares.
Insider Trade Summary
Grant/Award: 14,164 shares
Grant/Award
4 txns
Insider
ELLIS THOMAS B
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F4 | 14,164 | $0.00 | $0.00 |
| holding | Series A Convertible Preferred Stock F1, F2, F3 | -- | -- | -- |
| holding | Common Stock Purchase Warrants F2, F3 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 14,164 contracts (Direct);
Series A Convertible Preferred Stock — 7,213,115 contracts (Indirect, See Footnotes.);
Common Stock Purchase Warrants — 2,885,246 contracts (Indirect, See Footnotes.);
Common Stock — 32,292 shares (Direct)
Footnotes (4)
- F1. The securities do not have any expiration date.
- F2. The reported securities are directly held by NR-PRL Partners, LP, and may be deemed to be indirectly beneficially owned by NR-PRL Partners GP, LLC as the general partner of NR-PRL Partners, LP. The securities may also be deemed to be indirectly beneficially owned by the Reporting Person as a member of NR-PRL Partners GP, LLC.
- F3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission of beneficial ownership of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F4. The option is immediately exercisable, subject to a right of repurchase in favor of the Issuer with respect to shares issued to the Reporting Person upon exercise of the option prior to vesting. The option vests on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual meeting of stockholders (currently expected to be June 9, 2027), subject to the Reporting Person's continued service through such vesting date.
Key Figures
Stock options granted: 14,164 shares
Option exercise price: $6.00 per share
Option expiration: 2036-08-14
+5 more
8 metrics
Stock options granted
14,164 shares
Stock Option grant to Ellis on 2026-08-14
Option exercise price
$6.00 per share
Exercise price of newly granted Stock Option
Option expiration
2036-08-14
Expiration date of the 14,164-share Stock Option
Direct common stock held
32,292 shares
Direct GUER common stock ownership after reported transactions
Preferred underlying common shares
7,213,115 shares
Common shares underlying Series A Convertible Preferred Stock, held indirectly
Preferred conversion price
$327.87 per share
Conversion price for Series A Convertible Preferred Stock into GUER common
Warrant underlying common shares
2,885,246 shares
Common shares underlying Common Stock Purchase Warrants, held indirectly
Warrant exercise price
$3.05 per share
Exercise price for Common Stock Purchase Warrants
Key Terms
Stock Option, Series A Convertible Preferred Stock, Common Stock Purchase Warrants, right of repurchase, +1 more
5 terms
Stock Option financial
"The option is immediately exercisable, subject to a right of repurchase"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Series A Convertible Preferred Stock financial
"The reported securities are directly held by NR-PRL Partners, LP"
Series A convertible preferred stock is a class of shares sold in an early funding round that gives investors a mix of protection and upside: it pays a priority claim over common shares if the company is sold or closes, but can be converted into ordinary shares to share in future growth. Think of it like a hybrid between a safer stake and a ticket to ownership; it matters to investors because it affects who controls the company, how future gains are split, and how much their investment is protected from downside.
Common Stock Purchase Warrants financial
"Common Stock Purchase Warrants underlying_security_shares 2885246.0000"
Common stock purchase warrants are tradable instruments that give the holder the right to buy a company’s common shares at a set price before a specified date, like a coupon that lets you purchase stock later at a fixed rate. They matter to investors because they offer a way to gain future upside if the stock rises, but when exercised they increase the number of shares outstanding and can reduce existing shareholders’ ownership and earnings per share.
right of repurchase financial
"subject to a right of repurchase in favor of the Issuer"
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Thomas B. Ellis report in his latest Form 4 for GUER?
Thomas B. Ellis reported receiving a grant of 14,164 stock options for Guerrilla RF, Inc. common stock at an exercise price of $6.00 per share, along with updated disclosures of his direct and indirect equity and derivative holdings in the company.
What are the terms of the new stock options reported for GUER?
Ellis received 14,164 stock options with a $6.00 exercise price, expiring on August 14, 2036. They are immediately exercisable but subject to an issuer repurchase right until vesting, which occurs on the earlier of the first grant anniversary or GUER’s next annual stockholders’ meeting.
When are the newly granted GUER options expected to vest?
The options will vest on the earlier of one year from the grant date or the date of Guerrilla RF’s next annual stockholders’ meeting, currently expected to be June 9, 2027, subject to Ellis’s continued service through that vesting date.
What indirect derivative holdings in GUER does Ellis report?
Ellis reports indirect interests in Series A Convertible Preferred Stock convertible into 7,213,115 GUER common shares at $327.87 per share and warrants for 2,885,246 common shares at $3.05 per share, held through NR-PRL entities, with a pecuniary-interest-only beneficial ownership disclaimer.
What is the expiration date of Ellis’s GUER warrants and preferred stock?
The Common Stock Purchase Warrants for 2,885,246 GUER shares expire on February 5, 2030. The Series A Convertible Preferred Stock convertible into 7,213,115 common shares has no expiration date, as explicitly stated in the filing footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates